Literature DB >> 32394523

SNPs in PRKCA-HIF1A-GLUT1 are associated with diabetic kidney disease in a Chinese Han population with type 2 diabetes.

Yan Huang1, Li Jin1, Hairong Yu2, Guozhi Jiang3, Claudia H T Tam3, Song Jiang1, Chunxia Zheng1, Feng Jiang2, Rong Zhang2, Hong Zhang2, Juliana C N Chan3,4,5,6, Ronald C W Ma3,4,5,6, Weiping Jia2, Cheng Hu2,7,8, Zhihong Liu1.   

Abstract

OBJECTIVE: To explore the relationship between SNPs in PRKCA-HIF1A-GLUT1 and diabetic kidney disease in Chinese Han people.
MATERIALS AND METHODS: A total of 2552 participants from Shanghai Diabetes Institute Inpatient Database of Shanghai Jiao Tong University Affiliated Sixth People's Hospital were involved in the stage 1 cross-sectional population. A total of 6015 subjects from the Hong Kong Diabetes Register were included for validation. Genotyping of participants was conducted by the MassARRAY Compact Analyzer (Agena Bioscience). The data were analysed by plink, SAS, Haploview.
RESULTS: We identified variants associated with diabetic kidney disease in stage 1. Rs1681851 (P = .0105, OR = 1.331) in GLUT1 as well as rs2301108 (P = .0085, OR = 1.289) and rs79865957 (P = .0204, OR = 1.263) in HIF1A were significantly associated with diabetic kidney disease. Regarding DKD-related traits, rs1681851 was associated with plasma creatinine levels (P = .0169, β = 4.822) and eGFR (P = .0457, β = -6.956). Moreover, the results showed the interactions between PRKCA-GLUT1 in the occurrence of DKD. We further sought validation of the 17 SNPs in a prospective cohort and found that rs900836 and rs844501 were associated with the percentage change in eGFR slope. We performed a meta-analysis of case-control analysis data from the Hong Kong samples together with the stage 1 data from Shanghai. Rs9894851 showed significant correlation with the serum creatinine level as well as eGFR and no SNP showed association with DKD after meta-analysis.
CONCLUSIONS: Our results suggest potential association between SNPs in PRKCA-HIF1A-GLUT1 and diabetic kidney disease in Chinese Han people.
© 2020 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  zzm321990GLUT1zzm321990; zzm321990HIF1Azzm321990; zzm321990PRKCAzzm321990; SNP; diabetic kidney disease; type 2 Diabetes

Mesh:

Substances:

Year:  2020        PMID: 32394523     DOI: 10.1111/eci.13264

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet Rats.

Authors:  Yuansheng Liu; Qian Zhang; Lei Yang; Wencong Tian; Yinan Yang; Yuhang Xie; Jing Li; Liang Yang; Yang Gao; Yang Xu; Jie Liu; Yachen Wang; Jie Yan; Guoxun Li; Yanna Shen; Zhi Qi
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

2.  HIF-1α Pulmonary Phenotype Wide Association Study Unveils a Link to Inflammatory Airway Conditions.

Authors:  Jelte Kelchtermans; Xiao Chang; Michael E March; Frank Mentch; Patrick M A Sleiman; Hakon Hakonarson
Journal:  Front Genet       Date:  2021-09-21       Impact factor: 4.599

3.  Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway.

Authors:  Wei-Jian Ni; Xi-Mei Guan; Jing Zeng; Hong Zhou; Xiao-Ming Meng; Li-Qin Tang
Journal:  J Cell Mol Med       Date:  2022-01-09       Impact factor: 5.310

4.  Epigenetic Biomarkers Screening of Non-Coding RNA and DNA Methylation Based on Peripheral Blood Monocytes in Smokers.

Authors:  Xiaowei Huang; Bian Wu; Fangxue Zhang; Fancheng Chen; Yong Zhang; Huizhi Guo; Hongtao Zhang
Journal:  Front Genet       Date:  2022-02-11       Impact factor: 4.772

5.  Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.

Authors:  Jing Wei; Bo Wang; Feng-Jie Shen; Ting-Ting Zhang; Zan Duan; Dong-Mei Zhou
Journal:  BMC Nephrol       Date:  2022-07-27       Impact factor: 2.585

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.